Gallagher DJ - Search Results

1

Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications.

Tickoo SK, Milowsky MI, Dhar N, Dudas ME, Gallagher DJ, Al-Ahmadie H, Gopalan A, Fine SW, Ishill N, Bajorin DF, Reuter VE. Tickoo SK, et al. Among authors: gallagher dj. BJU Int. 2011 Mar;107(5):844-849. doi: 10.1111/j.1464-410X.2010.09517.x. Epub 2010 Aug 12. BJU Int. 2011. PMID: 20707797

2

Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting.

Gallagher DJ, Milowsky MI, Bajorin DF. Gallagher DJ, et al. Cancer. 2008 Sep 15;113(6):1284-93. doi: 10.1002/cncr.23692. Cancer. 2008. PMID: 18629841 Free article. Review.

3

Bladder cancer.

Gallagher DJ, Milowsky MI. Gallagher DJ, et al. Curr Treat Options Oncol. 2009 Aug;10(3-4):205-15. doi: 10.1007/s11864-009-0112-6. Curr Treat Options Oncol. 2009. PMID: 19771524 Review.

4

Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma.

Gallagher DJ, Milowsky MI, Iasonos A, Maluf FC, Russo P, Dalbagni G, Donat MS, Boyle MG, Zheng J, Riches J, Bajorin DF. Gallagher DJ, et al. Cancer. 2009 Nov 15;115(22):5193-201. doi: 10.1002/cncr.24570. Cancer. 2009. PMID: 19670454 Free article. Clinical Trial.

5

Phase II study of sunitinib in patients with metastatic urothelial cancer.

Gallagher DJ, Milowsky MI, Gerst SR, Ishill N, Riches J, Regazzi A, Boyle MG, Trout A, Flaherty AM, Bajorin DF. Gallagher DJ, et al. J Clin Oncol. 2010 Mar 10;28(8):1373-9. doi: 10.1200/JCO.2009.25.3922. Epub 2010 Feb 8. J Clin Oncol. 2010. PMID: 20142593 Clinical Trial.

6

False elevation of human chorionic gonadotropin in a patient with testicular cancer.

Gallagher DJ, Riches J, Bajorin DF. Gallagher DJ, et al. Nat Rev Urol. 2010 Apr;7(4):230-3. doi: 10.1038/nrurol.2010.10. Nat Rev Urol. 2010. PMID: 20383188

7

Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of response.

Gallagher DJ, Al-Ahmadie H, Ostrovnaya I, Gerst SR, Regazzi A, Garcia-Grossman I, Riches J, Gounder SK, Flaherty AM, Trout A, Milowsky MI, Bajorin DF. Gallagher DJ, et al. Eur Urol. 2011 Aug;60(2):344-9. doi: 10.1016/j.eururo.2011.05.034. Epub 2011 May 25. Eur Urol. 2011. PMID: 21645967

8

Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.

Gallagher DJ, Cronin AM, Milowsky MI, Morris MJ, Bhatia J, Scardino PT, Eastham JA, Offit K, Robson ME. Gallagher DJ, et al. BJU Int. 2012 Mar;109(5):713-9. doi: 10.1111/j.1464-410X.2011.10292.x. Epub 2011 Jul 14. BJU Int. 2012. PMID: 21756279 Free PMC article.

9

Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: argument in favor.

Gallagher DJ, Bajorin DF. Gallagher DJ, et al. Nat Clin Pract Urol. 2008 Sep;5(9):484-5. doi: 10.1038/ncpuro1147. Epub 2008 Jul 15. Nat Clin Pract Urol. 2008. PMID: 18626513 Review. No abstract available.

10

Detection of circulating tumor cells in patients with urothelial cancer.

Gallagher DJ, Milowsky MI, Ishill N, Trout A, Boyle MG, Riches J, Fleisher M, Bajorin DF. Gallagher DJ, et al. Ann Oncol. 2009 Feb;20(2):305-8. doi: 10.1093/annonc/mdn627. Epub 2008 Oct 3. Ann Oncol. 2009. PMID: 18836088 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters